Tetrapeptide caspase inhibitors exhibit protease- and substrate-dependent off-target specificity

Peptide-based caspase inhibitors are widely used to define the functions of individual caspases and were developed from tetrapeptide substrate preferences identified using positional scanning peptide libraries. Their specificity is typically validated using fluorogenic tetrapeptide substrates, yet whether these assays accurately predict inhibition of endogenous protein substrates has not been systematically examined. Here, we demonstrate that the widely used executioner caspase inhibitor zDEVD-FMK directly inhibits caspase-1 (CASP1)-mediated processing of interleukin-1β (IL-1β) and interleukin-18 (IL-18) despite CASP1 exhibiting minimal activity toward the DEVD fluorogenic substrate. Unexpectedly, zDEVD-FMK selectively inhibited CASP1 but not the closely related inflammatory caspases CASP4 or CASP5. Conversely, the CASP1 inhibitor Ac-YVAD-CMK directly inhibited CASP3-mediated protein substrate cleavage. We further found that endogenous substrates displayed markedly different sensitivities to inhibition, with IL-1β and IL-18 processing consistently inhibited more efficiently than gasdermin D cleavage, while fluorogenic CASP3/7 reporter cleavage substantially overestimated inhibition of endogenous apoptotic substrates. During inflammasome activation and Salmonella infection, DEVD- and YVAD-based inhibitors failed to distinguish apoptotic executioner caspase activity from inflammatory caspase signaling. Together, our findings demonstrate that fluorogenic tetrapeptide assays do not faithfully predict inhibition of endogenous protein substrates and identify protease- and substrate-dependent specificity as fundamental features of peptide-based caspase inhibitors.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.13.766510
Primary Topic
Cell death mechanisms and regulation
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Tetrapeptide caspase inhibitors exhibit protease- and substrate-dependent off-target specificity

Peter J. Gaskill, Cornelius Y. Taabazuing, Bohdana M. Discher, Christopher M. Bourne et al.
4 links
bioRxiv (Cold Spring Harbor Laboratory)
Cell death mechanisms and regulation
preprint

Tetrapeptide caspase inhibitors exhibit protease- and substrate-dependent off-target specificity

Peter J. Gaskill, Cornelius Y. Taabazuing, Bohdana M. Discher, Christopher M. Bourne, Marzieh Daniali, George M. Burslem, Jordi C. J. Hintzen, Haley Goodrow, Kithya Borey, Jacob D Liebovitz, Elizabeth Mitroka
preprint en

Abstract

Peptide-based caspase inhibitors are widely used to define the functions of individual caspases and were developed from tetrapeptide substrate preferences identified using positional scanning peptide libraries. Their specificity is typically validated using fluorogenic tetrapeptide substrates, yet whether these assays accurately predict inhibition of endogenous protein substrates has not been systematically examined. Here, we demonstrate that the widely used executioner caspase inhibitor zDEVD-FMK directly inhibits caspase-1 (CASP1)-mediated processing of interleukin-1β (IL-1β) and interleukin-18 (IL-18) despite CASP1 exhibiting minimal activity toward the DEVD fluorogenic substrate. Unexpectedly, zDEVD-FMK selectively inhibited CASP1 but not the closely related inflammatory caspases CASP4 or CASP5. Conversely, the CASP1 inhibitor Ac-YVAD-CMK directly inhibited CASP3-mediated protein substrate cleavage. We further found that endogenous substrates displayed markedly different sensitivities to inhibition, with IL-1β and IL-18 processing consistently inhibited more efficiently than gasdermin D cleavage, while fluorogenic CASP3/7 reporter cleavage substantially overestimated inhibition of endogenous apoptotic substrates. During inflammasome activation and Salmonella infection, DEVD- and YVAD-based inhibitors failed to distinguish apoptotic executioner caspase activity from inflammatory caspase signaling. Together, our findings demonstrate that fluorogenic tetrapeptide assays do not faithfully predict inhibition of endogenous protein substrates and identify protease- and substrate-dependent specificity as fundamental features of peptide-based caspase inhibitors.

bioRxiv (Cold Spring Harbor Laboratory)
Drexel University (US), University of Pennsylvania (US)
Burroughs Wellcome Fund, University of Pennsylvania, National Institutes of Health, National Institute on Drug Abuse, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases
Cell death mechanisms and regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon